Drug intelligence / Profile preview

Lactobacillus fritillae

Development stage: Preclinical
Lead developer: Nanchang University
Modality: Live Biotherapeutic Products → Microbiome Therapeutics

Overview

Lactobacillus fritillae is a specific bacterial species that has been investigated for its ability to inhibit sperm motility. Research, including a case series, has explored its co-incubation with sperm to understand this effect. The studies were conducted by Nanchang University and The Second Affiliated Hospital of Nanchang University.

Beyond the preview

Go deeper on Lactobacillus fritillae.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactobacillus fritillae.

Explore the full profile